This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Recombinant P-selectin glycoprotein ligand–immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial
- Paul Mertens, Alex Maes, Johan Nuyts, Ann Belmans, Walter Desmet, Enric Esplugas, Filip Charlier, Jaime Figueras, Gianmario Sambuceti, Markus Schwaiger, Luc Mortelmans, Frans Van de Werf
- American Heart Journal, July 2006, Elsevier
- DOI: 10.1016/j.ahj.2006.04.020